Septerna (SEPN) EBITDA (2023 - 2026)
Septerna's (SEPN) quarterly EBITDA came in at -$13.3 million in Q1 2026, up 48.67% year-on-year from -$8.9 million in Q1 2025, and up 16.99% quarter-over-quarter from -$16.0 million in Q4 2025.
Septerna (SEPN) EBITDA (2023 - 2026) Analysis & Trends
Septerna's EBITDA history runs 4 years deep, the most recent figure standing at -$13.3 million for Q1 2026.
- On a quarterly basis, EBITDA rose 48.67% year-over-year to -$13.3 million in Q1 2026; TTM through Mar 2026 was -$55.7 million, a 38.97% increase from a year earlier, with the FY2025 full-year figure at -$68.3 million, up 15.5% from the prior year.
- EBITDA rose to -$13.3 million in Q1 2026 per SEPN's latest filing, from -$16.0 million in the prior quarter.
- Across five years, EBITDA topped out at $34.3 million in Q4 2023 and bottomed at -$29.0 million in Q2 2025.
- The 4-year median for EBITDA is -$16.0 million (2025), against an average of -$12.7 million.
- Across the five-year window, EBITDA plunged 172.03% in 2024 and soared 111.59% in 2025, its largest moves.
- Year by year, EBITDA stood at $34.3 million in 2023, then tumbled by 172.03% to -$24.7 million in 2024, then surged by 35.18% to -$16.0 million in 2025, then gained by 16.99% to -$13.3 million in 2026.
- Per Business Quant, the three latest SEPN EBITDA figures stand at -$13.3 million (Q1 2026), -$16.0 million (Q4 2025), and $2.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Septerna | 1.50 Bn | 1.50 Bn | - | -13.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.30 Mn |
| Dec 31, 2025 | -16.02 Mn |
| Sep 30, 2025 | 2.61 Mn |
| Jun 30, 2025 | -28.98 Mn |
| Mar 31, 2025 | -25.91 Mn |
| Dec 31, 2024 | -24.72 Mn |
| Sep 30, 2024 | -22.55 Mn |
| Jun 30, 2024 | -18.07 Mn |
| Mar 31, 2024 | -15.49 Mn |
| Dec 31, 2023 | 34.32 Mn |
| Sep 30, 2023 | -12.04 Mn |